LATEST UPDATES » Vol 26, Nos. 07 & 08, July & August 2022 – Engineering a Sustainable Future       » Improving Crop Yield With Leaf Angles       » Combatting Tumours at the Gut With Novel Oral Vaccine Made by Bacteria Robot       » New Carbon Capture System With Record-Breaking Efficiency to Revolutionise Direct Air Capture       » Simulating the Synergistic Interactions of Neurons and Synapses in Computing Devices       » Understanding Gene Functions: From Algae to Plants       » Colour-Modified Mice Tissues Allow for Higher-Resolution Imaging      
Vol 26, Nos. 05 & 06, May & June 2022   |   Issue PDF view/purchase
Novel Intracellular Polymerisation Method for Precise Tumour Treatment
A novel intracellular polymerisation-based “prodrug” system can reduce tumour growth and metastasis while leaving main organs unaffected.

In the treatment of cancer, surgical intervention, radiotherapy, and chemotherapy are conventional options available for patients. Although chemotherapy is highly efficient, it is not without its severe toxicity and side effects. Hence, it would be ideal to develop drugs that can specifically target and be activated in/on cancerous cells. Lately, many prodrugs have been developed and used in cancer treatment to reduce side effects and promote efficacy.

Prodrugs are chemically modified drug molecules that release active drugs upon chemical transformation either by metabolic processes or external stimuli. External stimuli like light and synthetic molecules have to be introduced to the biological system to facilitate the transformation. Such stimuli are highly controllable, allowing for precise spatial and temporal control over the site of action.

In this study, a team of scientists from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences has developed a new method that uses light to induce intracellular control polymerisation to treat cancer.

Based on their previous studies, the team had investigated if it was possible to construct artificial polymers in living cells and discovered that intracellular polymerisation can alter the cell cycle, cytoskeleton structure, and cell motility.

In the present study, the scientists utilised the method of light-controlled photoinduced electron transfer-reversible addition-fragmentation chain-transfer (PET-RAFT) polymerisation as it provides greater control over the polymerisation process. With this method, they achieved polymer synthesis with predictable and controllable molecular weight and reduced molecular weight distribution, which improves the regularity of the polymer as well as the controllability and reproducibility of the intracellular polymerisation system.

The team also looked deeper into the application potential of the intracellular polymerisation system, screened a library of monomers for the purpose of tumour treatment, and innovated a precision tumour treatment system based on intracellular polymerisation. They then demonstrated that their system could reduce tumour growth and metastasis.

Concerned about side effects, the team verified the biosecurity of their novel intracellular polymerisation-based “prodrug” system, and observed that the body weight, haematological parameters, and histological characteristics of the main organs of the experimental animals remain unaffected by intracellular polymerisation or arbitrary component administration.

“We hope that the precision tumour treatment method based on intracellular polymerisation in our work will open a new era in polymer therapy for cancer treatment,” said Dr. Geng, lead author of the study.

Source: Zhang et al. (2022). Controlled Intracellular Polymerization for Cancer Treatment. JACS Au.

MGI Makes Possible New Advances in Agrigenomics Research and Molecular Breeding
news Medtec China 2022 Gathers Medtech Leading Enterprises, Optimising Medical Equipment Supply Chain by Creating Online-Offline Promotion Platforms
news Medtec China 2022 Is Now Open for Visitor Registration, Helping Medical Device Manufacturers in Medtech Sourcing and Supply Chain Stabilisation
news Inaugural Asia Summit on Global Health highlights Hong Kong's advantages
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy